Journal
JOURNAL OF MEDICINAL CHEMISTRY
Volume 51, Issue 13, Pages 3700-3712Publisher
AMER CHEMICAL SOC
DOI: 10.1021/jm7014556
Keywords
-
Categories
Ask authors/readers for more resources
The fluoroethoxy and fluoropropoxy substituted 2-(6-chloro-2-phenyl)imidazo[1,2-alpyridin-3-yl)-N,N-diethylacetamides 8 (PBR102) and 12 (PBR111) and 2-phenyl-5,7-dimethylpyrazolo[1,5-alpyrimidin-3-yl)-N,N-diethylacetamides 15 (PBR099) and 18 (PBR146) were synthesized and found to have high in vitro affinity and selectivity for the peripheral benzodiazepine receptors (PBRs) when compared with the central benzodiazepine receptors (CBRs). The corresponding radiolabeled compounds [F-18]8 [F-18]12, [F-18]15, and [F-18]18 were prepared from their p-toluenesulfonyl precursors in 50-85% radiochemical yield. In biodistribution studies in rats, the distribution of radioactivity of the [F-18]PBR compounds paralleled the known localization of PBRs. In the olfactory bulbs, where the uptake of radioactivity was higher than in the rest of the brain, PK11195 and Ro 5-4864 were able to significantly inhibit [F-18]12, while little or no pharmacological action of these established PBR drugs were observed on the uptake of [F-18]8, [F-18]15, and [F-18]18 compared to control animals. Hence, [F-18]12 appeared to be the best candidate for evaluation as an imaging agent for PBR expression in neurodegenerative disorders.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available